Vitrolife Group

The Vitrolife Group is a world-leading global provider of medical devices and genetic testing testing solutions.

Dedicated to the reproductive-health market since 1994, we have grown by focusing on product development, groundbreaking research, consistent quality control and acquisitions of innovative companies in the industry.

In 2021, Vitrolife acquired Igenomix, a leader in reproductive genetic testing services primarily for IVF clinics.

Together we are now the Vitrolife Group, a global leader in reproductive health focused on supporting our customers and patients worldwide to improve treatment outcomes – always with sustainability in mind.